Johnson & Johnson: all 3,718 studies

Page 2 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety DisorderRecruitingNCT06701903Phase 2
• Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric PatientsRecruitingNCT06690398Phase 3
• A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06667908Phase 2
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06667076Phase 2
• A Long-term Extension (LTE) Study of Guselkumab in Pediatric ParticipantsRecruitingNCT06663332Phase 3
• A Study of JNJ-89402638 for Metastatic Colorectal and Gastric CancersRecruitingNCT06663319Phase 1
• A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerRecruitingNCT06662786Phase 3
• FORWARD CAD IDE StudyRecruitingNCT06662500Not applicable
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaRecruitingNCT06651567Phase 2
• Impella RP Flex with Smart AssistRecruitingNCT06637644
• A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)RecruitingNCT06635148Phase 2/3
• EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))RecruitingNCT06631638Not applicable
• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsRecruitingNCT06559306Phase 3
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseaseRecruitingNCT06540833Phase 2
• A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)RecruitingNCT06533098Phase 3
• The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese PopulationRecruitingNCT06510205
• A Study to Evaluate Preventive Treatments for GPRC5D-related Oral EventsRecruitingNCT06500884Phase 2
• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety DisorderRecruitingNCT06480383Phase 2
• A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)RecruitingNCT06449651Phase 3
• A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck CancerRecruitingNCT06385080Phase 1/2
• Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsRecruitingNCT06372964Phase 3
• INHANCE Stemless Reverse Shoulder IDERecruitingNCT06323980Not applicable
• A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerRecruitingNCT06319820Phase 3
• A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid TumorsRecruitingNCT06311578Phase 1
• Abiomed Impella RT-DAQ - Observational StudyRecruitingNCT06308055
• Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic LeukemiaRecruitingNCT06299540
• A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical TrialsRecruitingNCT06285318
• Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderRecruitingNCT06229210Phase 3
• A Study of JNJ-87890387 for Advanced Solid TumorsRecruitingNCT06178614Phase 1
• A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsRecruitingNCT06150157Phase 1
• A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate CancerRecruitingNCT06095089Phase 1
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT05923073Phase 3
• A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)RecruitingNCT05912517Phase 3
• Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderRecruitingNCT05850689Phase 3
• A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate CancerRecruitingNCT05818683Phase 1
• A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisRecruitingNCT05652335Phase 1
• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaRecruitingNCT05552222Phase 3
• A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerRecruitingNCT05498428Phase 2
• A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerRecruitingNCT05379595Phase 1/2
• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple MyelomaAvailableNCT05346835
• Impella ECP Study (ECP Study) and Impella ECP Continued Access ProtocolEnrolling by invitationNCT05334784Not applicable
• Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT05327114Phase 2/3
• A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia GravisRecruitingNCT05265273Phase 2/3
• A Long-term Study for Participants Previously Treated With Ciltacabtagene AutoleucelRecruitingNCT05201781Phase 4
• A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionRecruitingNCT05179876Phase 3
• A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple MyelomaRecruitingNCT05160584
• Efficacy of the COronary SInus Reducer in Patients With Refractory Angina IIRecruitingNCT05102019Not applicable
• A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisRecruitingNCT04951622Phase 3Results posted
• JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCRecruitingNCT04892173Phase 3
• Post Market Clinical Follow-up Study on TVT ABBREVO® Continence SystemRecruitingNCT04829357
• Ethicon Pelvic Mesh Post Market Clinical Follow-up RegistryRecruitingNCT04829175
• A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)RecruitingNCT04811560Phase 1/2
• An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac ArrhythmiasRecruitingNCT04750798
• A Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT04634552Phase 2
• A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative ColitisRecruitingNCT04372108
• Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact LensesCompletedNCT07076160Not applicableResults posted
• Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration ProcessCompletedNCT06967129Not applicableResults posted
• Clinical Evaluation of Two Cosmetic Contact LensesCompletedNCT06864858Not applicableResults posted
• Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of WearCompletedNCT06749496Not applicableResults posted
• Evaluation of Lens Rotation in Habitual Wearers of Toric, Soft Contact LensesCompletedNCT06649019Not applicableResults posted
• A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and PleasureTerminatedNCT06635135Phase 3Results posted
• Clinical Investigation of the TECNIS® Next-Generation Intraocular LensCompletedNCT06377514Not applicableResults posted
• Evaluation of the Clinical Performance of Daily Disposable Silicone Hydrogel Multifocal Toric Contact LensesCompletedNCT06377488Not applicableResults posted
• Evaluation of Acuvue Oasys 1-Day Contact Lenses in New WearersCompletedNCT06333613Not applicableResults posted
• Stone Access and Removal (STAR) StudyCompletedNCT06330701Not applicableResults posted
• A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisActive, not recruitingNCT06295692Phase 3Results posted
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)Active, not recruitingNCT06220604Phase 3Results posted
• Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of WearCompletedNCT06161012Not applicableResults posted
• A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisActive, not recruitingNCT06143878Phase 3Results posted
• A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or OlderCompletedNCT06134804Phase 3Results posted
• Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye DropCompletedNCT06131476Phase 1Results posted
• A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque PsoriasisActive, not recruitingNCT06095115Phase 3Results posted
• A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)Active, not recruitingNCT06095102Phase 3Results posted
• Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque PsoriasisCompletedNCT06039189Phase 3Results posted
• A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid ArthritisCompletedNCT06028438Phase 2Results posted
• A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE GeneratorCompletedNCT05971693Not applicableResults posted
• A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound CatheterCompletedNCT05970120Not applicableResults posted
• Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)CompletedNCT05966662Not applicableResults posted
• A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy AdultsCompletedNCT05901636Phase 1/2Results posted
• FORWARD PAD IDE Study With the Shockwave Javelin IVL CatheterCompletedNCT05858905Not applicableResults posted
• Initial Clinical Experience With the MONARCH Platform, Urology for the Treatment of Kidney StonesCompletedNCT05835323Not applicableResults posted
• Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye DropsCompletedNCT05814367Phase 2Results posted
• A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical ResectionTerminatedNCT05784129Phase 3Results posted
• Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking ChromophoreCompletedNCT05778786Not applicableResults posted
• Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery DiseaseActive, not recruitingNCT05755711Results posted
• A Study For Treatment Of Paroxysmal Atrial Fibrillation (PAF) With The THERMOCOOL SMARTTOUCH SF Catheter and TRUPULSE GeneratorCompletedNCT05752487Not applicableResults posted
• Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy VolunteersCompletedNCT05732194Phase 1Results posted
• Evaluation of ACUVUE® OASYS 1-Day for Astigmatism Contact Lenses With Alternative LidstockCompletedNCT05713552Not applicableResults posted
• Premedication to Reduce Amivantamab Associated Infusion Related ReactionsActive, not recruitingNCT05663866Phase 2Results posted
• Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing PatientsCompletedNCT05661851Phase 2Results posted
• A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular CarcinomaTerminatedNCT05653427Phase 2Results posted
• The Effects of Contact Lenses With UV/HEV-Filter on Visual FunctionCompletedNCT05601544Not applicableResults posted
• Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot StudyCompletedNCT05582304Not applicableResults posted
• Clinical Investigation of Healon EndoCoat Ophthalmic Viscosurgical Device (OVD)CompletedNCT05575063Not applicableResults posted
• Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens, Model DEN00VTerminatedNCT05574959Not applicableResults posted
• A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell LymphomaCompletedNCT05564052Phase 2Results posted
• Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact LensesCompletedNCT05554640Not applicableResults posted
• A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF)CompletedNCT05552963Not applicableResults posted
• A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant TherapyCompletedNCT05550532Phase 3Results posted
• A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT05528510Phase 3Results posted

← Johnson & Johnson overview and focus areas